Exhibit 107

 

Calculation of Filing Fee Table

 

FORM S-8
(Form Type)

 

Rigel Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Newly Registered Securities

 

    Security Type   Security
Class
Title
  Fee
Calculation
Rule
  Amount
Registered(1)
  Proposed
Maximum
Offering
Price
Per Unit
  Maximum
Aggregate
Offering
Price
  Fee Rate   Amount of
Registration
Fee(2)
 
Fees to Be Paid   Equity(3)   Common Stock, $0.001 par value per share   Rules 457(c) 
and 457(h)
    356,000   $ 1.26   $ 448,560.00     .00011020   $ 49.43  
    Equity(4)   Common Stock, $0.001 par value per share   Rules 457(c) 
and 457(h)
    4,000,000     1.26     5,040,000.00     .00011020     555.41  
                                             
    Total Offering Amounts                           $ --  
    Total Fee Offsets                           $ --  
        Net Fee Due                           $ 604.84  

 

(1) Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement shall also cover any additional shares of Registrant’s Common Stock that become issuable under the plans set forth herein by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Registrant’s Common Stock, as applicable.

 

(2) Estimated in accordance with Rules 457(c) and 457(h) solely for the purpose of calculating the registration fee on the basis of $1.26 per share, the average of the high and low prices of the Registrant’s Common Stock on July 25, 2023 as reported on the Nasdaq Global Select Market.

 

(3) Represents shares of the Registrant’s Common Stock that were added to the Rigel Pharmaceuticals, Inc. Inducement Plan, as amended, pursuant to share reserve increases approved by the Registrant’s Board of Directors.

 

(4) Represents shares of the Registrant’s Common Stock that were added to the Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended, pursuant to a share reserve increase approved by the Registrant’s Board of Directors and the Registrant’s stockholders.